McKesson Stock Price, News & Analysis

McKesson Corporation (NYSE:MCK) has announced the acquisition of Rx Savings Solutions for up to $875 million to enhance access, affordability, and adherence solutions for patients. The deal includes a $600 million upfront payment and an additional $275 million contingent on RxSS's performance through 2025. This acquisition aims to strengthen McKesson's ecosystem, leveraging RxSS's technology in reducing prescription costs and enhancing patient medication adherence. The acquisition is expected to close in the second half of Fiscal 2023.

McKesson Corporation (NYSE:MCK) has announced the appointment of LeAnn B. Smith as the new executive vice president and chief human resources officer (CHRO), effective December 1, 2022. She will succeed Tracy L. Faber, who is retiring after 11 years. Smith, who joined McKesson in 2021, will oversee all human resources functions, focusing on talent management, diversity, and organizational change. CEO Brian Tyler expressed confidence in Smith's capabilities, highlighting her extensive experience, including a previous role at Walmart.

McKesson Corporation (NYSE: MCK) announced its fiscal 2023 first-quarter financial results, now available on its Investor Relations website. The company will host a live webcast today, August 3, at 4:30 PM ET to discuss these results. McKesson continues to lead in healthcare services, collaborating with various sectors to enhance care accessibility and affordability. The press release indicates a commitment to delivering insights and services that improve health outcomes across the healthcare spectrum.

On July 22, 2022, McKesson Corporation (NYSE:MCK) declared a regular dividend of $0.54 per share, marking a 15% increase from the previous $0.47. The dividend will be payable on October 3, 2022, to shareholders of record as of September 1, 2022. CEO Brian Tyler emphasized the dividend increase reflects robust cash flow and the company’s confidence in its long-term growth strategy. Notably, this marks the sixth consecutive year of dividend increases for McKesson.

McKesson Corporation (NYSE: MCK) will announce its first quarter fiscal 2023 financial results on August 3, 2022, after market close. The company will conduct a live webcast at 4:30 PM Eastern Time to discuss the results. Investors can access the webcast and related financial documentation on the company’s Investor Relations website. McKesson is committed to improving health outcomes and providing affordable healthcare solutions through partnerships with various stakeholders in the healthcare sector.

McKesson Corporation and HCA Healthcare have announced a joint venture to combine their oncology research arms, US Oncology Research and Sarah Cannon Research Institute, enhancing clinical trial access and drug development. This venture aims to expand oncology research, streamline trial matching for patients, and improve access, particularly for underserved communities. McKesson will hold 51% ownership, with the joint venture expected to close in 2022. Financial details remain undisclosed, and the agreement is subject to regulatory approvals.

McKesson Corporation and HCA Healthcare have announced a joint venture to combine their oncology research efforts, enhancing clinical trials and treatment options for cancer patients. The venture will merge McKesson’s US Oncology Research with HCA’s Sarah Cannon Research Institute, aiming to improve access and accelerate cancer drug development, especially in underserved communities. McKesson will hold a 51% stake and operating control. The deal is expected to close in 2022, pending regulatory approval and customary conditions.

McKesson Corporation (NYSE: MCK) announced its fiscal 2022 fourth-quarter financial results, which are accessible through its Investor Relations website. A live webcast of the earnings conference call is scheduled for May 5 at 4:30 PM ET, allowing investors to review the results in detail. McKesson aims to enhance healthcare accessibility and affordability through partnerships with various healthcare entities. More information is available on their official website.

AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) have settled opioid-related claims with the Washington Attorney General, agreeing to pay up to $518 million. This payment resolves lawsuits filed by the state and its subdivisions, allowing for the dismissal of ongoing litigation. The settlement aligns with a previously announced agreement effective April 2, 2022, aimed at addressing a significant portion of opioid claims against the distributors. The companies dispute the allegations but see this as steps toward broader resolutions and relief for impacted communities.